Search Results - "HINOJOSA, Joaquin"
-
1
Succinate receptor mediates intestinal inflammation and fibrosis
Published in Mucosal immunology (2019)“…Succinate, an intermediate of the tricarboxylic acid cycle, is accumulated in inflamed areas and its signaling through succinate receptor (SUCNR1) regulates…”
Get full text
Journal Article -
2
Old-age inflammatory bowel disease onset:A different problem
Published in World journal of gastroenterology : WJG (14-06-2011)“…Inflammatory bowel disease (IBD) in patients aged 60 accounts for 10%-15% of cases of the disease. Diganostic methods are the same as for other age groups…”
Get full text
Journal Article -
3
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients
Published in Inflammatory bowel diseases (01-06-2013)“…To evaluate the safety of thiopurines in patients with inflammatory bowel disease. To identify predictive factors associated with the development of…”
Get full text
Journal Article -
4
Relationship between Serum Adalimumab Levels and Clinical Outcome in the Treatment of Inflammatory Bowel Disease
Published in Digestive diseases (Basel) (2019)“…Adalimumab (ADA) is an anti-tumor necrosis factor agent that has been shown to be effective in inducing and maintaining remission in adult patients with…”
Get more information
Journal Article -
5
M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis
Published in PloS one (22-10-2013)“…Macrophages, which exhibit great plasticity, are important components of the inflamed tissue and constitute an essential element of regenerative responses…”
Get full text
Journal Article -
6
ApaI Polymorphism in the Vitamin D Receptor Gene Decreases the Risk of Perianal Fistulas in Crohn's Disease
Published in Nutrients (14-10-2024)“…Vitamin D, through the activation of its receptor (VDR), plays an immunomodulatory role in the gastrointestinal tract. Single-nucleotide polymorphisms (SNPs)…”
Get full text
Journal Article -
7
Timing of surgery in Crohn's disease: a key issue in the management
Published in World journal of gastroenterology : WJG (28-09-2008)“…The timing of the decision for operation in Crohn's disease is based on an evaluation of the several factors such as the failure of medical treatment,…”
Get full text
Journal Article -
8
Clinical settings with tofacitinib in ulcerative colitis
Published in Revista española de enfermedades digestivas (01-09-2024)“…There are aspects of Janus kinase (JAK) inhibitors, specifically tofacitinib, that distinguish them from other drugs used in the treatment of ulcerative…”
Get full text
Journal Article -
9
Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process
Published in PloS one (31-10-2012)“…Inflammation is part of a complex biological response of vascular tissue to pathogens or damaged cells. First inflammatory cells attempt to remove the…”
Get full text
Journal Article -
10
Diminished Vitamin D Receptor Protein Levels in Crohn's Disease Fibroblasts: Effects of Vitamin D
Published in Nutrients (01-04-2020)“…Vitamin D (VD) deficiency has been associated to Crohn's disease (CD) pathogenesis, and the exogenous administration of VD improves the course of the disease,…”
Get full text
Journal Article -
11
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Published in Digestive diseases (Basel) (2019)“…The association between infliximab (IFX) and fecal calprotectin (FC) levels on one hand, and the clinical and endoscopic response of patients with inflammatory…”
Get more information
Journal Article -
12
Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial
Published in Journal of Crohn's and colitis (27-10-2017)“…Postoperative recurrence of Crohn's disease [POR-CD] is almost certain if no prophylaxis is administered. Evidence for optimal treatment is lacking. Our aim…”
Get full text
Journal Article -
13
A Single Nucleotide Polymorphism in the Vitamin D Receptor Gene Is Associated With Decreased Levels of the Protein and a Penetrating Pattern in Crohn's Disease
Published in Inflammatory bowel diseases (08-06-2018)“…Abstract Background Vitamin D signaling modulates inflammation through the vitamin D receptor (VDR). The synonymous single nucleotide polymorphism (SNP)…”
Get full text
Journal Article -
14
Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease
Published in Gastroenterología y hepatología (01-03-2020)“…Recommendations are advice that is given and considered to be beneficial; however, they are still suggestions and are therefore open to different…”
Get more information
Journal Article -
15
GADECCU 2022 Guideline for the treatment of Ulcerative Colitis. Adaptation and updating of the GETECCU 2020 Guideline
Published in Gastroenterología y hepatología (01-03-2023)“…Ulcerative colitis (UC) is a chronic inflammatory disease that compromises the colon, affecting the quality of life of individuals of any age. In practice,…”
Get more information
Journal Article -
16
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease
Published in Revista española de enfermedades digestivas (01-06-2019)“…therapeutic monitoring of anti-TNF drugs and anti-drug antibody levels are useful for clinical decision-making, via the rationalization and optimization of the…”
Get full text
Journal Article -
17
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn’s disease
Published in European journal of gastroenterology & hepatology (01-05-2020)“…The aims of this study were (a) to know the kinetics of antitumor necrosis factor (TNF) drug serum levels during the induction phase in patients with Crohn's…”
Get full text
Journal Article -
18
Joint position statement by “Sociedad Española de Patología Digestiva” (Spanish Society of Gastroenterology) and “Sociedad Española de Farmacología” (Spanish Society of Pharmacology) on biosimilar therapy for inflammatory bowel disease
Published in Revista española de enfermedades digestivas (01-01-2013)“…Biological drugs or biopharmaceutical products, manufactured with or from living organisms using biotechnology, have represented a therapeutic revolution for…”
Get full text
Journal Article -
19
Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome
Published in Journal of Crohn's and colitis (01-10-2013)“…Information on efficacy and predictors of response to adalimumab in ulcerative colitis (UC) clinical practice is limited. Assessment of response to adalimumab…”
Get full text
Journal Article -
20
Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps
Published in Gastroenterología y hepatología (01-06-2015)“…Information received by IBD patients about their disease is of particular importance. The objective of the study was to determine the information resources…”
Get more information
Journal Article